Diamyd will now present their 21-month follow-up data on the 18th of September in Amsterdam (previously 26th of September).
More info on what the study is about can be found in the post below.
15-month data released summer 2006 was said to be very good results for a Phase II study.
Tuesday, September 11, 2007
21 month follow-up update
Posted by
webmaster
at
4:51 PM
Labels: diabetes, diamyd, stem cell, type 1 diabetes
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment